Journal
CLINICAL GENETICS
Volume 77, Issue 1, Pages 37-48Publisher
WILEY
DOI: 10.1111/j.1399-0004.2009.01282.x
Keywords
ARVC; ARVD; desmosome; genetics; sudden death
Categories
Funding
- Fondation de l'Institut de Cardiologie de Montreal (Canada)
- Instituto de Salud Carlos III/FIS
- Sociedad Espanola de Cardiologia: Beca para formacion en centros extranjeros (Spain)
Ask authors/readers for more resources
In a cohort of patients with confirmed or suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), genetic testing is useful in confirming the diagnosis, particularly in individuals who do not completely fulfil Task Force criteria for the disease, thereby also enabling the adoption of preventive measures in family members. Due to the high percentage of novel mutations that are expected to be identified in ARVC/D, the use of genetic screening technology based on the identification of known mutations seems to have very restricted value. Our results support that the presence of certain genetic variations could play a role in the final phenotype of patients with ARVC/D, where single and compound mutation carriers would have more symptomatic forms of the disease and the polymorphism P366L could be associated to a more benign phenotype.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available